MYCOSES (BERLIN. INTERNET)

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

DE

tipo

journal

publicação venue de

A contemporary investigation of burden and natural history of aspergillosis in people living with HIV / AIDS. 00:1-1. 2023-01-01
Clinical, radiological and laboratory characteristics of central nervous system histoplasmosis: A systematic review of a severe disease. 3:1. 2023-01-01
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease. 1:1-X. 2023-01-01
Genotyping and antifungal susceptibility testing of isolates from Southern Brazil. 00:1-9. 2023-01-01
Metagenomics reveals an abundance of black yeast-like fungi in the skin microbiome. 00:1-9. 2023-01-01
Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis. -:---. 2023-01-01
Onychomycosis in immunocompromised population: Phenotypic and molecular identification. 1:1. 2023-01-01
Seasonality of sporotrichosis in Brazil: A modelled analysis of the epidemic in São Paulo, 2011-2020. 1:1-8-650. 2023-01-01
Sporotrichosis co-infection with human immunodeficiency virus/acquired immunodeficiency syndrome. 1:1. 2023-01-01
A lateral flow assay for the immunodiagnosis of human cat-transmitted sporotrichosis. 00:1-9. 2022-01-01
A systematic review of neuroparacoccioidomyocosis: the contribution of neuroimaging. 66:168-175. 2022-01-01
COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes. 65:449-457. 2022-01-01
Compulsory notification of paracoccidioidomycosis: A 14-year retrospective study of the disease in the state of Paraná, Brazil. 65:354-361. 2022-01-01
Current Situation of Endemic Mycosis in the Americas and the Caribbean: Proceedings of the First International Meeting on Endemic Mycoses of the Americas ( IMEMA ). 00:1-1187. 2022-01-01
Emergence of in intensive care units in Algeria. 65:753-759. 2022-01-01
Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020. 00:1-10. 2022-01-01
Global prevalence and subgroup analyses of coronavirus disease ( -19) associated infections ( ): A systematic review and meta-analysis. 65:683-703. 2022-01-01
In vitro activity of 23 antifungal drugs against 54 clinical and environmental isolates. 65:981-988. 2022-01-01
Metabolic and phenotypic plasticity may contribute for the higher virulence of over other Trichosporonaceae members. 00:000-11. 2022-01-01
Molecular characterisation of isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in conferring reduced susceptibility to echinocandins. 65:331-343. 2022-01-01
Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil. 00:1-10. 2022-01-01
Optimization of a commercial Histoplasma Galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil. -:--10. 2022-01-01
Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil. 00:1-723. 2022-01-01
South Asian (Clade I) meningitis in a paediatric patient in Iran with a review of the literature. 65:134-139. 2022-01-01
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil. -:--1118. 2022-01-01
What to expect when AGEP is induced by terbinafine? case report and critical review of the literature. 00:1-8. 2022-01-01
What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature. 00:1-8. 2022-01-01
A pseudo-outbreak of in a bronchoscopy unit of a tertiary care teaching hospital in London, United Kingdom. 64:394-404. 2021-01-01
Activities of nine antifungal agents against biofilms. 64:381-384. 2021-01-01
Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil. 00:1-1072. 2021-01-01
CATastrophe: Response to the challenges of zoonotic sporotrichosis in southern Brazil. .:--5. 2021-01-01
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series. 64:457-464. 2021-01-01
Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment. 64:1092-1097. 2021-01-01
Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance. 65:1-311. 2021-01-01
Comparative genomics of opportunistic Ph ialophora species involved in divergent disease types. 00:555-14. 2021-01-01
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. 64:1028-1037. 2021-01-01
EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis. 64:1542-1545. 2021-01-01
Endemic mycoses: Expansion of traditional geographic ranges and pitfalls in management. 64:989-992. 2021-01-01
Evaluation of DermaGenius resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant species. 64:721-726. 2021-01-01
Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.. .:.-.. 2021-01-01
Host immune responses in dermatophytes infection. 1:1-483. 2021-01-01
In vitro activities of 8 antifungal drugs against 126 clinical and environmental Exophiala isolates. 00:1328-1333. 2021-01-01
Invasive fungal infections in acute and chronic liver impairment: A systematic review. 65:140-151. 2021-01-01
MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of species from Iranian clinical samples. 64:918-925. 2021-01-01
Paracoccidioidomycosis due to P. lutzii : the importance of neutrophil/lymphocyte ratio in the symptomatic and asymptomatic phases in severe cases. 1:1-467. 2021-01-01
Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids. 1:1-1. 2021-01-01
Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids. 64:817-822. 2021-01-01
(1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality. 64:264-271. 2020-01-01
Acanthamoeba castellanii as an alternative interaction model for the dermatophyte Trichophyton rubrum. 00:00-00. 2020-01-01
Alternative treatment of fungal infections: synergy with non¿antifungal agents. 00:1-13. 2020-01-01
Antidermatophytic Activity of Synthetic Peptides: Action mechanisms and clinical application as adjuvants to enhance the activity and decrease the toxicity of Griseofulvin. -:--14. 2020-01-01
Antifungal drugs: An updated review of central nervous system pharmacokinetics. 6:1047-1059. 2020-01-01
Burden of serious fungal infections in the Netherlands. 63:625-631. 2020-01-01
Candida spp bloodstream infections in a Latin American Pediatric Oncology Reference Center: Epidemiology and associated factors. 1:1-4. 2020-01-01
Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil. 63:145-150. 2020-01-01
Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole. 1:1-227. 2020-01-01
Discovery of a novel and selective fungicide that targets fungal cell wall to treat dermatomycoses: 1,3-bis(3,4-dichlorophenoxy)propan-2-aminium chloride. 63:197-211. 2020-01-01
Epidemiological features of nosocomial candidaemia in neonates, infants and children: A multicentre study in Iran. 63:382-394. 2020-01-01
Epidemiology of invasive fungal disease in haematologic patients. 64:252-256. 2020-01-01
European confederation of medical mycology expert consult-An ECMM excellence center initiative. 63:566-572. 2020-01-01
Expression of genes containing tandem repeat patterns involved in the fungal-host interaction and in the response to antifungals in Trichophyton rubrum. 1:610-616. 2020-01-01
First azole-resistant isolates with the environmental TR /Y121F/T289A mutation in Iran. 63:430-436. 2020-01-01
Genotypic diversity in clinical and environmental isolates of from India using multilocus microsatellite and multilocus sequence typing. 63:284-293. 2020-01-01
Hospitalizations for mycoses as an indicator of socio-environmental vulnerability in the Brazilian Amazon-Savanna transition region. 63:151-161. 2020-01-01
In vitro antidermatophytic synergism of double and triple combination of clioquinol with ciclopirox and terbinafine. 00:1-1001. 2020-01-01
Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. 64:152-156. 2020-01-01
Isothermal nucleic acid amplification techniques for detection and identification of pathogenic fungi: A review. -:---. 2020-01-01
Molecular typing, in vitro susceptibility, and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from southeastern Brazil. 00:1-11. 2020-01-01
Molecular-based assessment of diversity and population structure of Sporothrix spp. clinical isolates from Espírito Santo-Brazil. 1:1-427. 2020-01-01
New insights on evolutionary aspects of Pythium insidiosum and other peronosporaleans. 1:1-12. 2020-01-01
Oral Paracoccidioidomycosis affecting Women: a Systematic Review. 64:108-122. 2020-01-01
Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. 1:1-151. 2020-01-01
Synergistic association of clioquinol with antifungal drugs against biofilm forms of clinical isolates. 00:1-1082. 2020-01-01
The interaction between Sporothrix schenckii sensu stricto and Sporothrix brasiliensis with Acanthamoeba castellanii. 63:302-307. 2020-01-01
Visualization of penetration of topical antifungal drug substances through mycosis-infected nails by matrix assisted laser desorption ionization mass spectrometry imaging. x:xx-xx. 2020-01-01

tem uma área de assunto

publisher

Wiley-Blackwell

is open access

False invalid format

is in DOAJ

False invalid format